Multiple Myeloma: Management Strategies for Improved Outcomes
Join Kenneth Anderson, MD, William Bensinger, MD, and Carol Ann Huff, MD, for this didactic and case-based symposium which addresses 1) current and emergent treatment options for multiple myeloma (MM) across the disease spectrum, including transplant; 2) therapeutic approaches in maintenance, relapsed and refractory MM as relates to patient selection; and 3) optimizing outcomes by reducing skeletal events and managing bone disease in MM.
This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.
In particular, faculty and learners will collectively:
- Evaluate currently available conventional treatment strategies in MM
- Address the mechanism of action and rationale for molecular targeted therapy approaches in maintenance and relapsed/refractory MM, and discuss characteristics of patients who may benefit from these approaches
- Assess treatment approaches, including use of single-agent, combination, and sequenced regimens alongside agents that can reduce skeletal events/improve overall survival in the management of MM
- Identify and evaluate the factors that affect the choice and response to induction therapy for transplant- and non-transplant-eligible patients with MM
- 2.00 Participation
- 2.00 Nurse
- 2.00 Pharmacist
- 2.00 Physician